TWI816666B - Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake - Google Patents

Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake Download PDF

Info

Publication number
TWI816666B
TWI816666B TW107111853A TW107111853A TWI816666B TW I816666 B TWI816666 B TW I816666B TW 107111853 A TW107111853 A TW 107111853A TW 107111853 A TW107111853 A TW 107111853A TW I816666 B TWI816666 B TW I816666B
Authority
TW
Taiwan
Prior art keywords
ketogenic diet
intake
acetone concentration
animal
mentioned
Prior art date
Application number
TW107111853A
Other languages
Chinese (zh)
Other versions
TW201842316A (en
Inventor
芦田欣也
Original Assignee
日商明治股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商明治股份有限公司 filed Critical 日商明治股份有限公司
Publication of TW201842316A publication Critical patent/TW201842316A/en
Application granted granted Critical
Publication of TWI816666B publication Critical patent/TWI816666B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/497Physical analysis of biological material of gaseous biological material, e.g. breath
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/202499Formaldehyde or acetone
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25875Gaseous sample or with change of physical state

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本發明之目的在於:獲得一種對動物之生酮飲食之有效狀態個別地進行管理之生酮飲食監測裝置。本發明之生酮飲食監測裝置具有如下構成:對自生酮飲食之有效狀態受到管理之動物體內排出體外之氣體中之代謝物量進行1次及/或複數次經時測定、監測。生酮飲食監測裝置1具有:攝取資訊獲取部,其獲取攝取至動物體內之生酮飲食之攝取量之資訊;丙酮濃度測定部,其對自動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定;及判定部,其基於藉由攝取資訊獲取部所獲取之生酮飲食之攝取量之資訊、及藉由丙酮濃度測定部所測定之丙酮濃度之資訊,判定動物之生酮飲食之代謝狀態。 The object of the present invention is to obtain a ketogenic diet monitoring device that individually manages the effective state of the ketogenic diet of animals. The ketogenic diet monitoring device of the present invention is configured to measure and monitor the amount of metabolites in the gas excreted from the body of an animal whose ketogenic diet is being managed once and/or multiple times over time. The ketogenic diet monitoring device 1 has: an intake information acquisition unit that acquires information on the intake of the ketogenic diet into the animal's body; and an acetone concentration measurement unit that measures the acetone amount in the gas excreted from the animal's body, that is, the acetone concentration. and a determination unit that determines the metabolism of the animal's ketogenic diet based on the information on the intake of the ketogenic diet obtained by the intake information acquisition unit and the information on the acetone concentration measured by the acetone concentration measuring unit. condition.

Description

生酮飲食之有效狀態之監測裝置及生酮飲食攝取量之管理方法 Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake

本發明係一種用以管理生酮飲食之有效狀態之監測裝置。 The present invention is a monitoring device used to manage the effective status of a ketogenic diet.

在此之前,猜想生酮飲食、高脂肪飲食(尤其是糖類限制高脂肪飲食)可成為針對終末期癌症患者之治療方法之一,於是對生酮飲食對日本國人之終末期肺癌患者之有效性進行了研究,結果發現:藉由生酮飲食、例如包括糖類限制高脂肪飲食此類用以治療癌症之組合物或其等之組合,較佳為藉由將脂肪設為120g以上,及/或將碳水化合物限制於每日30g以下,及/或將每日攝取之卡路里設為20kcal/kg體重以上,及/或將中鏈脂肪酸油(MCT油)等進行組合,會以出乎意料之顯著效果治療癌症,改善生活品質(QOL,Quality of life)(專利文獻1)。 Prior to this, it was speculated that ketogenic diet and high-fat diet (especially sugar-restricted high-fat diet) could become one of the treatments for end-stage cancer patients. Therefore, the effectiveness of ketogenic diet on Japanese end-stage lung cancer patients was investigated. Research was conducted and it was found that compositions for treating cancer through a ketogenic diet, such as a high-fat diet including sugar restriction, or a combination thereof, are preferably made by setting the fat to 120g or more, and/or Limiting carbohydrates to less than 30g per day, and/or setting the daily calorie intake to more than 20kcal/kg of body weight, and/or combining medium-chain fatty acid oils (MCT oils), etc., will have unexpectedly significant effects. It is effective in treating cancer and improving quality of life (QOL) (Patent Document 1).

又,已知生酮飲食能有效改善腦功能及預防、治療認知功能障礙(專利文獻2)。進而,已知生酮飲食對肥胖症、循環器官疾病、2型糖尿病、癲癇、痤瘡、癌症、多嚢性卵巢症候群、神經障礙、阿茲海默症、帕金森氏症、頭部外傷具有療效(非專利文獻1)。 Furthermore, it is known that the ketogenic diet can effectively improve brain function and prevent and treat cognitive dysfunction (Patent Document 2). Furthermore, the ketogenic diet is known to be effective in treating obesity, circulatory disease, type 2 diabetes, epilepsy, acne, cancer, polycystic ovary syndrome, neurological disorders, Alzheimer's disease, Parkinson's disease, and head trauma ( Non-patent literature 1).

在此之前,為了提供一種用以抑制胃排出量之上升且延遲胃排出之食品用劑或醫療用劑,曾進行銳意研究,於此過程中發現了如下方法,即:藉由對被投予13C標記之各種胺基酸之動物的13CO2之呼氣排泄量進行監測,而將呼氣作為檢體,非侵入性地測定胺基酸之代謝量(專利文獻3)。 Prior to this, intensive research was conducted in order to provide a food or medical agent that suppresses an increase in gastric discharge and delays gastric discharge. In the process, the following method was discovered: by administering The amount of 13CO 2 exhaled by animals labeled with 13C-labeled various amino acids is monitored, and the amount of amino acid metabolism is measured non-invasively using exhaled breath as a sample (Patent Document 3).

根據一般認知,動物所攝取之生酮飲食於動物體內會被代謝,其一部分成為丙酮,而作為呼氣或者自皮膚或黏膜排出體外之氣體,自動物體內向體外排泄。 作為氣體中之丙酮之測定方法,已知有多功能呼氣分析器(專利文獻4)、呼氣測定裝置(專利文獻5)等。 又,已知有利用呼氣丙酮量來推定糖尿病指標值之系統(專利文獻6)。 [先前技術文獻] [專利文獻] 專利文獻1:國際公開第2017/038101號公報 專利文獻2:國際公開第2016/013617號公報 專利文獻3:日本專利第5938219號公報 專利文獻4:日本專利第5921562號公報 專利文獻5:日本專利第5139186號公報 專利文獻6:日本專利特開2015-102381號公報 [非專利文獻] 非專利文獻1:European Journal of Clinical Nu trition (2013) 67, 789-796According to general knowledge, the ketogenic diet ingested by animals will be metabolized in the animal's body, and part of it will become acetone, which will be excreted from the body into the body as exhalation or gas excreted from the skin or mucous membranes. As a method for measuring acetone in gas, a multifunctional breath analyzer (Patent Document 4), a breath measurement device (Patent Document 5), and the like are known. In addition, a system for estimating diabetes index values using the amount of exhaled acetone is known (Patent Document 6). [Prior Art Document] [Patent Document] Patent Document 1: International Publication No. 2017/038101 Patent Document 2: International Publication No. 2016/013617 Patent Document 3: Japanese Patent No. 5938219 Patent Document 4: Japanese Patent No. Publication No. 5921562 Patent Document 5: Japanese Patent Publication No. 5139186 Patent Document 6: Japanese Patent Publication No. 2015-102381 [Non-patent Document] Non-Patent Document 1: European Journal of Clinical Nutrition (2013) 67, 789-796

[發明所欲解決之問題] 在此之前,並未聽說有為了管理動物之生酮飲食之有效狀態而對自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之代謝物量進行測定之監測裝置。更未聽說有為了於攝取生酮飲食時管理生酮飲食之有效狀態,或者為了將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象來管理生酮飲食之有效狀態,或者作為食用攝取生酮飲食之輔助方法、或作為對是否為可將生酮飲食作為酮體來源有效地代謝之體況或體質進行核查或判斷之方法,而對自動物體內排出體外之氣體中之丙酮量進行測定之監測裝置。 於動物之生酮飲食之有效狀態之管理中,認為只要可非侵入性地以即時或持續等方式對排出體外之氣體中之丙酮量進行測定,來監測動物之生酮飲食作為酮體來源之代謝狀態,便可對生酮飲食之有效狀態個別地進行管理。即,此種裝置之開發即為課題所在。 [解決問題之技術手段] 本發明人經過銳意努力,發現了對自動物體內排出體外之氣體中之丙酮量進行1次及/或複數次經時測定、監測之裝置及其使用方法,從而完成了本發明。 根據本發明,其提供以下發明。 [1]一種監測裝置,其為了管理生酮飲食之有效狀態,而對自動物體內排出體外之氣體中之丙酮量進行1次及/或複數次測定。 [2]如[1]所記載之監測裝置,其為了管理生酮飲食之有效狀態,而進行1次及/或複數次測定,且上述動物係攝取生酮飲食能有效醫治之疾病之患者及/或準患者。 [3]如[1]所記載之監測裝置,其中上述生酮飲食之有效狀態之管理係為了與攝取生酮飲食前後之動物體內之代謝一併管理生酮飲食之攝取而進行1次及/或複數次測定。 [4]如[1]所記載之監測裝置,其中上述生酮飲食之有效狀態之管理係為了核查對象者對生酮飲食之有效狀態之維持、改善之適性而進行1次及/或複數次測定。 又,本案發明之生酮飲食監測裝置之特徵在於:其係對生酮飲食之有效性進行監測者,且具有:攝取資訊獲取部,其獲取攝取至動物體內之生酮飲食之攝取量之資訊;丙酮濃度測定部,其對自上述動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定;及判定部,其基於藉由上述攝取資訊獲取部所獲取之上述生酮飲食之攝取量之資訊、及藉由上述丙酮濃度測定部所測定之上述丙酮濃度之資訊,判定上述動物之上述生酮飲食之代謝狀態。 較佳為上述判定部係基於攝取上述生酮飲食前後之上述丙酮濃度之增減而進行上述判定。並且,較佳為於與攝取上述生酮飲食前相比,上述丙酮濃度表現出增加傾向之情形時,上述判定部判定上述動物係將上述生酮飲食作為酮體來源而代謝之狀態、或者上述動物係可將上述生酮飲食作為酮體來源而代謝之體況或體質。 [發明之效果] 根據本發明,其可提供一種對自動物體內排出體外之氣體中之代謝物量進行1次及/或複數次經時測定、監測之裝置及其使用方法。並且,藉由提供本發明之監測裝置及其使用方法,可於攝取生酮飲食時管理生酮飲食之有效狀態,或者可將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象來管理生酮飲食之有效狀態,或者作為食用攝取生酮飲食之輔助方法而對是否為可將生酮飲食作為酮體來源有效地代謝之體況或體質進行核查或判斷。 根據本發明,其可提供一種於動物攝取了生酮飲食之情形時,對自動物體內排出體外之氣體中之丙酮量進行1次及/或複數次經時測定、監測之裝置及其使用方法。 根據本發明,其可提供一種對自攝取生酮飲食能有效醫治之疾病之患者及/或準患者的體內排出體外之氣體中之丙酮量進行1次及/或複數次經時測定、監測之裝置及其使用方法。 根據本發明之監測裝置,其可對自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之代謝物量進行測定,而管理動物之生酮飲食之有效狀態。 根據本發明之監測裝置,其可於動物攝取了生酮飲食之情形時,對自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之代謝物量進行測定,而管理動物之生酮飲食之有效狀態。 根據本發明之監測裝置,其可將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象,對自動物體內排出體外之氣體中之丙酮量進行測定,並將該酮體來源之代謝率考慮在內,而進行飲食管理,如調整飲食中之糖類與脂類之平衡性等。關於生酮飲食,因口味欠佳,故存在難以出於喜愛而大量攝取之情形。 根據本發明,其可藉由一面進行監測一面調整攝取,而僅按充分必要量即適度量進行攝食,從而可避免過度攝取並不喜愛之生酮飲食。根據本發明,其兼具如下效果,即:可藉由一面進行監測一面調整生酮飲食之攝取(藉由使能有效維持或改善體況之生酮飲食之攝食量變得明確),而使攝食動物(尤其是人)有意識或無意識地進行攝食。 根據本發明之監測裝置,其可對自動物體內排出體外之氣體中之丙酮量進行測定,而核查或判斷是否為可將生酮飲食作為酮體來源有效地代謝之體況或體質。 與本發明相關之更多特徵可根據本說明書之記述、隨附圖式而明瞭。又,上述內容以外之課題、構成及效果可藉由以下實施形態之說明而明瞭。[Problem to be solved by the invention] Until now, it has not been heard that in order to manage the effective state of the ketogenic diet of animals, the gases excreted from the body (exhalation, evaporation from the skin or mucous membranes) A monitoring device for measuring the amount of metabolites. Furthermore, I have not heard of any attempt to manage the effective state of the ketogenic diet while taking the ketogenic diet, or to manage the effective state of the ketogenic diet for patients and/or prospective patients with diseases that can be effectively treated by taking the ketogenic diet. Or as an auxiliary method for consuming a ketogenic diet, or as a method to check or judge whether the body condition or constitution can effectively metabolize the ketogenic diet as a source of ketone bodies, and to remove gases excreted from the body automatically. A monitoring device for measuring the amount of acetone. In the management of the effective state of the ketogenic diet of animals, it is considered that as long as the amount of acetone in the gas excreted from the body can be measured non-invasively in real time or continuously, the ketogenic diet of animals can be monitored as a source of ketone bodies. Metabolic state, the effective state of the ketogenic diet can be managed individually. That is, the development of such a device is the subject. [Technical Means for Solving the Problem] The present inventor, through dedicated efforts, discovered a device and a method of using it to measure and monitor the amount of acetone in the gas discharged from the body once and/or multiple times over time, thereby completing of the present invention. According to the present invention, it provides the following invention. [1] A monitoring device that measures the amount of acetone in the gas excreted from the body once and/or multiple times in order to manage the effective state of the ketogenic diet. [2] The monitoring device as described in [1], which performs one and/or multiple measurements in order to manage the effectiveness of the ketogenic diet, and the above-mentioned animal is a patient with a disease that can be effectively cured by taking the ketogenic diet, and /or prospective patients. [3] The monitoring device according to [1], wherein the management of the effective state of the ketogenic diet is performed once and/or in order to manage the metabolism of the animal's body before and after the ketogenic diet is ingested. Or multiple measurements. [4] The monitoring device according to [1], wherein the management of the effective state of the ketogenic diet is performed once and/or multiple times in order to check the subject's suitability for maintaining and improving the effective state of the ketogenic diet. Determination. Furthermore, the ketogenic diet monitoring device of the present invention is characterized in that it monitors the effectiveness of the ketogenic diet and has an intake information acquisition unit that acquires information on the intake of the ketogenic diet into the animal's body. ; an acetone concentration measurement unit that measures the amount of acetone in the gas excreted from the body of the animal, that is, the acetone concentration; and a determination unit that determines the intake amount of the ketogenic diet based on the intake information acquisition unit Information, and the information of the acetone concentration measured by the acetone concentration measuring unit, determine the metabolic state of the ketogenic diet of the above-mentioned animal. Preferably, the determination unit performs the determination based on an increase or decrease in the acetone concentration before and after ingesting the ketogenic diet. Furthermore, it is preferable that when the acetone concentration shows a tendency to increase compared with before ingesting the ketogenic diet, the determination unit determines that the animal metabolizes the ketogenic diet as a source of ketone bodies, or the above-mentioned The animal is in a physical condition or constitution that can metabolize the above-mentioned ketogenic diet as a source of ketone bodies. [Effects of the Invention] According to the present invention, it is possible to provide a device for measuring and monitoring the amount of metabolites in the gas excreted from the body once and/or multiple times over time and a method of using the same. Furthermore, by providing the monitoring device and its usage method of the present invention, the effective state of the ketogenic diet can be managed while ingesting the ketogenic diet, or patients and/or prospective patients with diseases that can be effectively treated by the ketogenic diet can be treated as The object is to manage the effective status of the ketogenic diet, or as an auxiliary method for consuming the ketogenic diet, to check or judge whether the ketogenic diet is a body condition or constitution that can effectively metabolize the ketogenic diet as a source of ketone bodies. According to the present invention, when an animal consumes a ketogenic diet, it is possible to provide a device for measuring and monitoring the amount of acetone in the gas excreted from the body once and/or multiple times over time and a method of using the same. . According to the present invention, it is possible to provide a method for measuring and monitoring the amount of acetone in the gas excreted from the body of patients and/or prospective patients who have a disease that can be effectively treated by taking a ketogenic diet once and/or multiple times over time. Device and method of use. According to the monitoring device of the present invention, it can measure the amount of metabolites in the gas excreted from the body of the animal (exhalation, evaporation from the skin or mucous membrane), and manage the effective state of the animal's ketogenic diet. According to the monitoring device of the present invention, when an animal ingests a ketogenic diet, it can measure the amount of metabolites in the gas excreted from the body (exhalation, evaporation from the skin or mucous membranes), and manage the animal. The effective state of the ketogenic diet. According to the monitoring device of the present invention, it can target patients and/or prospective patients with diseases that can be effectively treated by taking a ketogenic diet, measure the amount of acetone in the gas excreted from the body, and determine the source of the ketone body. Taking into account the metabolic rate, dietary management is carried out, such as adjusting the balance of carbohydrates and lipids in the diet. Regarding the ketogenic diet, because the taste is not good, it may be difficult to consume a large amount out of love. According to the present invention, it is possible to adjust the intake while monitoring and only eat a sufficient and necessary amount, that is, an appropriate amount, thereby avoiding excessive intake of an unfavorable ketogenic diet. According to the present invention, it has the following effect: by monitoring and adjusting the intake of the ketogenic diet (by clarifying the amount of food intake of the ketogenic diet that can effectively maintain or improve body condition), the feeding animal ( Especially humans) eat consciously or unconsciously. According to the monitoring device of the present invention, it can measure the amount of acetone in the gas excreted from the body, and check or determine whether the body condition or constitution can effectively metabolize the ketogenic diet as a source of ketone bodies. Further features related to the present invention will become clear from the description of this specification and the accompanying drawings. In addition, problems, structures, and effects other than those described above will become clear from the following description of the embodiments.

以下,對本發明之較佳之實施形態詳細地進行說明,但本發明並不限定於以下所述之各個形態。 作為於本發明中可使用之對象之動物,可列舉任意之哺乳動物,例如可列舉:小鼠、大鼠、倉鼠、豚鼠等嚙齒類,兔子等兔科,豬、牛、山羊、馬、綿羊等蹄科,狗、貓等貓科,人、猿猴、羅猴、食蟹猴、狨猴、猩猩、黑猩猩等靈長類等。哺乳動物較佳為嚙齒類(小鼠等)或靈長類(人等),更佳為靈長類,進而更佳為人。 於本發明中,所謂生酮飲食之有效狀態,係指動物自體外攝取生酮飲食,並將生酮飲食有效地用於動物之活體維持或動物之生活活動之狀態。生酮飲食之有效狀態可由將生酮飲食作為酮體來源而有效地代謝之狀態進行判斷,例如可根據自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之丙酮量之狀態進行判斷。自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之丙酮量可按絕對量及/或相對量進行管理。又,由於存在動物個體差異,故而對於自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之丙酮量,只要是根據同一個體中未攝取生酮飲食之時期與攝取生酮飲食之時期、或者生酮飲食之攝取前或攝取後之丙酮量之上升、降低及/或增加等來進行判斷即可,若與攝取生酮飲食前相比,表現出一定之增加傾向,則可判斷出其具有上述效果。例如,該增加傾向更佳為於統計學上表現出有意義之差。 又,即便為同一個體中未攝取生酮飲食之時期與攝取生酮飲食之時期、或者生酮飲食之攝取前或攝取後之丙酮量之差固定的狀態,其效果亦得到維持,從而可判斷出其較佳。 於本發明中,所謂生酮飲食之有效狀態之管理,係指掌握生酮飲食作為酮體來源被有效地代謝之狀態,並試圖於目標範圍內維持及/或改善動物之體況。 於本發明中,所謂生酮飲食,係指可於動物活體內產生酮體之飲食或食品。例如為高脂肪飲食、中鏈脂肪酸飲食、酮體酯、調配有酮原性胺基酸之食品。又,於本發明中,有時將該等生酮飲食稱為酮體來源飲食。 其中,作為用以治療癌症之生酮飲食或其組合,例如可列舉生酮飲食、尤其是高脂肪飲食(例如所謂之「糖類限制高脂肪飲食」)。上述自癌症患者之體內排出體外之氣體例如可列舉呼氣、自皮膚或黏膜排出體外之氣體。 於本發明中,生酮飲食之有效狀態受到管理之動物可為攝取生酮飲食能有效醫治之疾病之患者及/或準患者等,於本發明中,攝取生酮飲食能有效醫治之疾病可列舉肥胖症、循環器官疾病、2型糖尿病、癲癇、痤瘡、癌症、多嚢性卵巢症候群、神經障礙、阿茲海默症、帕金森氏症、頭部外傷。 於本發明中,所謂攝取生酮飲食能有效醫治之疾病之患者,係指被診斷出患有上述疾病者,所謂準患者,係指被診斷出有可能罹患上述疾病、或存在罹患上述疾病之傾向及/或徵兆者。又,所謂準患者,進而包括自遺傳學上而言罹患上述疾病之可能性較高者、及/或基於自身意願希望攝取生酮飲食以預防上述疾病者。 於本發明中,可藉由本發明裝置進行監測,以便於攝取生酮飲食之前後確定生酮飲食之攝取量。又,可藉由本發明裝置進行監測,以便核查或判斷上述生酮飲食之有效狀態受到管理之動物是否為可於攝取生酮飲食後將生酮飲食作為酮體來源而有效地代謝之體況或體質。 圖1及圖2係表示本實施形態之監測裝置之例之功能方塊圖。 例如如圖1所示,監測裝置1具備監測終端裝置2與監測管理裝置3。監測終端裝置2與監測管理裝置3經由通信電路4而連接,可相互進行資訊之收發。監測終端裝置2具有包含丙酮濃度測定部21a之測定部21與包含判定顯示部22a之顯示部22。並且,監測管理裝置3具有資料獲取部31與判定部32。 監測終端裝置2之丙酮濃度測定部21a對自動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定。並且,判定顯示部22a顯示藉由監測管理裝置3之判定部32所獲得之判定結果。 監測管理裝置3之資料獲取部31獲取生酮飲食之攝取資訊、丙酮濃度之資訊、及攝取生酮飲食之動物之個體資訊。生酮飲食之攝取資訊中包含向動物體內攝取之生酮飲食之攝取量之資訊,進而亦可包含生酮飲食之攝取時刻、攝取期間、種類等資訊中之至少一者。並且,動物之個體資訊中可包含動物之種類、年齡、性別、體格、體況、體質、患病名稱等資訊中之至少一者。 生酮飲食之攝取資訊與動物之個體資訊係自設置於監測終端裝置2或監測管理裝置3之未圖示之輸入機構輸入至資料獲取部31。即,資料獲取部31作為攝取資訊獲取部,獲取生酮飲食之攝取資訊。並且,丙酮濃度之資訊係自丙酮濃度測定部21a獲取。 判定部32基於生酮飲食之攝取資訊與丙酮濃度之資訊,而判定動物之生酮飲食之代謝狀態。判定部32對生酮飲食是否被作為酮體來源而有效地代謝,即動物體內是否產生有酮體進行判定。判定部32例如基於攝取生酮飲食前後之丙酮濃度之增減而進行代謝狀態之判定。於與生酮飲食之攝取前相比,攝取後之丙酮濃度表現出增加傾向之情形時,判定部32判定該動物係將生酮飲食作為酮體來源而有效地代謝之狀態、或者動物係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。 判定部32例如基於動物之單位體重(Kg)之生酮飲食攝取量(g)、及攝取生酮飲食前後之丙酮濃度之差,算出因攝取生酮飲食而產生之丙酮濃度之增加率。並且,與預先設定之基準值進行比較,於超過基準值之情形時,丙酮濃度表現出增加傾向,因此判斷為動物係將生酮飲食作為酮體來源而有效地代謝之狀態、或者動物係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。另一方面,於基準值以下之情形時丙酮濃度未表現出增加傾向,因此判斷為動物係未將生酮飲食作為酮體來源而有效地代謝之狀態、或者動物並非係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。又,例如,亦可對丙酮濃度之增加率是否屬於被設定了階梯性範圍之複數個代謝等級(等級1~5)中之某一者進行判定。 亦可基於動物之個體資訊,來修正基準值或代謝等級之範圍。例如,亦可為於成人男性等體格較大之動物之情形時向提高基準值之方向修正,而於成人女性或兒童等體格較小之動物之情形時,向降低基準值之方向修正。 判定部32之判定結果顯示於監測終端裝置2之判定顯示部22a。因此,藉由察看判定顯示部22a,可瞭解攝取生酮飲食對該動物是否有效。修正可依據行政機關等所發表之統計資訊、論文發表/學會發表等公開資訊、基於個人積累之資料而獲得之非公開資訊等來進行。該修正可人為地進行,亦可利用AI(人工智能)等功能來實現。 根據具有上述構成之監測裝置1,可基於判定結果而確定生酮飲食自下次起之攝取量。又,可判斷出動物是否係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。並且,亦可藉由持續地進行記錄,而掌握動物之體況或體質之變化。 根據監測裝置1,關於生酮飲食,即,可將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象而進行飲食管理,如調整飲食中之糖類與脂類之平衡性等者,因口味欠佳,故存在難以出於喜愛而大量攝取之情形,但可一面藉由監測裝置1進行監測一面調整攝取,因此可僅按充分必要量即適度量進行攝取,從而可避免過度攝取並不喜愛之生酮飲食。根據監測裝置1,能有效維持或改善體況之生酮飲食之攝食量變得明確。因此,兼具可使攝食動物(尤其是人)有意識或無意識地進行攝食之效果。 監測裝置1可為將顯示測定結果之判定的判定部32與顯示判定之判定顯示部22a直接連接而於一處進行監測之裝置,亦可為通過通信電路4將包含上述測定部21及判定顯示部22a之監測終端裝置2與具有處理資料之資料獲取部31及判定生酮飲食之有效狀態之判定部32之監測管理裝置3連接的監測裝置1(圖1)。通信電路4可列舉電波、各種公知之無線通信線路或有線通信線路等。監測可為實時,亦可有一定之時間差。又,監測可於一處進行,亦可於複數處,例如患者本人、醫生、護士、檢查技師、營養師、管理設備、生酮飲食生產者等處進行。 又,亦可包含監測終端裝置、及監測管理裝置,其中監測終端裝置包含測定部、判定顯示部、及接收並顯示判斷之判斷顯示部;監測管理裝置包含資料獲取部、判定部、儲存判定部之判定之判定儲存部、及根據所儲存之判定進行判斷之判定判斷部(圖2)。 監測終端裝置可為如同手錶或眼鏡般之形狀,亦可為裝飾品或皮帶等容易穿戴於身上之任何形態。進而,亦可具有連動地管理複數個監測終端裝置之監測管理伺服器。藉由監測管理伺服器,例如亦可用以根據複數個患者之治療成績而確定通常最佳之治療量。 作為監測終端裝置或監測管理裝置,可使用包括個人電腦、超級電腦等在內之所有數位電腦,亦可使用行動電話、智慧型手機、平板、警報裝置等。 圖3係表示本實施形態之監測裝置之整體構成之功能方塊圖。 監測終端裝置2包含測定丙酮濃度之丙酮濃度測定部、及顯示來自判定等發送部之資料之顯示部,顯示部中包含判定顯示部。又,亦可具有顯示來自判定等發送部之資料之判斷顯示部。進而,亦可包含1個或複數個對生酮飲食之有效狀態管理有用之其他測定部。 監測管理裝置3包含獲取測定資料之資料獲取部、記錄測定資料之記錄部、及根據資料判定被代謝之酮體來源飲食量之判定部。又,亦可具有預先儲存判定之判定儲存部、及根據所儲存之判定核查或判斷是否需要調整飲食之攝食量或脂肪量、及可否適應生酮飲食之判定判斷部。來自判定部之判定及來自判定判斷部之判斷經由判定等發送部被發送至判定顯示部或判斷顯示部並顯示於監測終端裝置。監測管理裝置中亦可包含資料記錄部。 圖4係表示本實施形態之監測裝置之構成之功能方塊圖。 監測裝置1具有監測終端裝置2A~2C、監測管理裝置3A~3C、及將其等連接之通信電路4A~4C。可具有複數個監測終端裝置,亦可具有1個及/或複數個管理複數個監測終端裝置之監測管理裝置,進而,亦可具有用以於上位管理監測管理裝置之監測管理伺服器。 本發明包含使用本發明之監測裝置之方法或使用方法、生酮飲食之評估方法、生酮飲食攝取量之管理方法、攝食生酮飲食能有效醫治之動物之核查等使用本發明之監測裝置之一切形態,且可應用於所有形態。 以上,對本發明之實施形態進行了詳細說明,但本發明並不限定於上述實施形態,而可於不脫離申請專利範圍所記載之本發明精神之範圍內,進行各種設計變更。Preferred embodiments of the present invention will be described in detail below, but the present invention is not limited to each of the following embodiments. Examples of animals that can be used in the present invention include any mammals. Examples include rodents such as mice, rats, hamsters, and guinea pigs; Leporidae such as rabbits; pigs, cattle, goats, horses, and sheep. Isodactylidae, cats such as dogs and cats, humans, apes, rhesus monkeys, cynomolgus monkeys, marmosets, orangutans, chimpanzees and other primates. The mammal is preferably a rodent (mouse, etc.) or a primate (human, etc.), more preferably a primate, and still more preferably a human. In the present invention, the so-called effective state of the ketogenic diet refers to the state in which the animal ingests the ketogenic diet from outside the body, and the ketogenic diet is effectively used for the animal's living maintenance or the animal's life activities. The effectiveness of a ketogenic diet can be judged by the state of effective metabolism of the ketogenic diet as a source of ketone bodies. For example, it can be based on the amount of acetone in the gas excreted from the body (exhalation, evaporation from the skin or mucous membranes) judge the status. The amount of acetone in the gas excreted from the animal body (expiration, evaporation from the skin or mucous membranes) can be managed based on absolute amounts and/or relative amounts. In addition, due to individual differences among animals, the amount of acetone in the gas excreted from the body (exhalation, evaporation from the skin or mucous membranes) can be determined based on the period when the same individual did not take a ketogenic diet and the time when they took a ketogenic diet. It can be judged by the increase, decrease and/or increase in the amount of acetone before or after the ketogenic diet is taken or during the ketogenic diet. If there is a certain increase trend compared to before the ketogenic diet is taken, It can be judged that it has the above effects. For example, the increasing tendency is preferably a statistically significant difference. Furthermore, even if the difference in the amount of acetone between the period of not ingesting the ketogenic diet and the period of ingesting the ketogenic diet is fixed in the same individual, or the difference in the amount of acetone before or after ingestion of the ketogenic diet is constant, it can be judged that the effect is maintained The best. In the present invention, the management of the effective state of the ketogenic diet refers to grasping the state in which the ketogenic diet as a source of ketone bodies is effectively metabolized, and trying to maintain and/or improve the body condition of the animal within the target range. In the present invention, the so-called ketogenic diet refers to a diet or food that can produce ketone bodies in a living animal. Examples include high-fat diets, medium-chain fatty acid diets, ketone body esters, and foods formulated with ketogenic amino acids. In addition, in the present invention, these ketogenic diets may be referred to as ketone body-derived diets. Among them, examples of ketogenic diets or combinations thereof used to treat cancer include ketogenic diets, especially high-fat diets (for example, so-called "carbohydrate-restricted high-fat diets"). Examples of the gas excreted from the body of a cancer patient include exhalation and gas excreted from the skin or mucous membranes. In the present invention, the animals that are managed in an effective state of the ketogenic diet may be patients and/or prospective patients with diseases that can be effectively treated by taking the ketogenic diet. In the present invention, the diseases that can be effectively treated by taking the ketogenic diet can be List obesity, circulatory disease, type 2 diabetes, epilepsy, acne, cancer, polycystic ovary syndrome, neurological disorders, Alzheimer's disease, Parkinson's disease, and head trauma. In the present invention, the so-called patients with diseases that can be effectively treated by taking a ketogenic diet refer to those who have been diagnosed with the above-mentioned diseases, and the so-called prospective patients refer to those who have been diagnosed with the possibility of suffering from the above-mentioned diseases, or those who have the above-mentioned diseases. tendencies and/or symptoms. In addition, the so-called prospective patients further include those who are genetically more likely to suffer from the above-mentioned diseases, and/or those who wish to eat a ketogenic diet to prevent the above-mentioned diseases based on their own wishes. In the present invention, the device of the present invention can be used for monitoring, so as to determine the intake of the ketogenic diet before and after the intake of the ketogenic diet. In addition, monitoring can be performed by the device of the present invention in order to check or determine whether the animal under management of the above-mentioned ketogenic diet is in a body condition that can effectively metabolize the ketogenic diet as a source of ketone bodies after ingesting the ketogenic diet or Physique. 1 and 2 are functional block diagrams showing an example of the monitoring device of this embodiment. For example, as shown in FIG. 1 , the monitoring device 1 includes a monitoring terminal device 2 and a monitoring management device 3 . The monitoring terminal device 2 and the monitoring management device 3 are connected via the communication circuit 4 and can exchange information with each other. The monitoring terminal device 2 has a measurement unit 21 including an acetone concentration measurement unit 21a and a display unit 22 including a determination display unit 22a. Furthermore, the monitoring and management device 3 has a data acquisition unit 31 and a determination unit 32 . The acetone concentration measuring unit 21a of the monitoring terminal device 2 measures the amount of acetone in the gas discharged from the body, that is, the acetone concentration. Moreover, the judgment display part 22a displays the judgment result obtained by the judgment part 32 of the monitoring management apparatus 3. The data acquisition unit 31 of the monitoring and management device 3 acquires the intake information of the ketogenic diet, the information of the acetone concentration, and the individual information of the animals ingesting the ketogenic diet. The intake information of the ketogenic diet includes information on the intake amount of the ketogenic diet ingested into the animal's body, and may further include at least one of the information on the time, period, type, etc. of the ketogenic diet being ingested. Furthermore, the individual information of the animal may include at least one of the animal's species, age, gender, physique, body condition, constitution, disease name, and other information. The intake information of the ketogenic diet and the individual information of the animal are input to the data acquisition unit 31 from an input mechanism (not shown) provided in the monitoring terminal device 2 or the monitoring management device 3 . That is, the data acquisition unit 31 serves as an intake information acquisition unit and acquires intake information on the ketogenic diet. Furthermore, the information on the acetone concentration is obtained from the acetone concentration measuring unit 21a. The determination unit 32 determines the metabolic state of the animal on the ketogenic diet based on the ketogenic diet intake information and the acetone concentration information. The determination unit 32 determines whether the ketogenic diet is efficiently metabolized as a source of ketone bodies, that is, whether ketone bodies are produced in the animal's body. The determination unit 32 determines the metabolic state based on, for example, an increase or decrease in the acetone concentration before and after ingestion of the ketogenic diet. When the acetone concentration after ingestion of the ketogenic diet shows a tendency to increase compared with that before ingestion of the ketogenic diet, the determination unit 32 determines that the animal is in a state of effectively metabolizing the ketogenic diet as a source of ketone bodies, or that the animal is capable of A body condition or constitution that effectively metabolizes the ketogenic diet as a source of ketone bodies. The determination unit 32 calculates the increase rate of the acetone concentration due to the ingestion of the ketogenic diet based on, for example, the ketogenic diet intake (g) per unit body weight (Kg) of the animal and the difference in acetone concentration before and after the ketogenic diet is ingested. Furthermore, when compared with the preset reference value, the acetone concentration tends to increase when it exceeds the reference value. Therefore, it is judged that the animal is in a state of effectively metabolizing the ketogenic diet as a source of ketone bodies, or that the animal is able to A body condition or constitution that effectively metabolizes the ketogenic diet as a source of ketone bodies. On the other hand, the acetone concentration does not show an increasing tendency when it is below the reference value. Therefore, it is judged that the animal is not in a state of effectively metabolizing the ketogenic diet as a source of ketone bodies, or that the animal is not able to use the ketogenic diet as a source of ketone bodies. A body condition or constitution that can efficiently metabolize ketone bodies from a source. Furthermore, for example, it may be determined whether the increase rate of the acetone concentration belongs to one of a plurality of metabolic levels (levels 1 to 5) in which a stepwise range is set. The range of the baseline value or metabolic level can also be corrected based on the individual information of the animal. For example, in the case of larger animals such as adult males, the correction may be made in the direction of increasing the reference value, and in the case of smaller animals such as adult women or children, the correction may be made in the direction of lowering the reference value. The determination result of the determination unit 32 is displayed on the determination display unit 22a of the monitoring terminal device 2. Therefore, by looking at the determination display part 22a, it can be understood whether ingesting the ketogenic diet is effective for the animal. Corrections can be made based on statistical information published by administrative agencies, etc., public information such as paper publications/society publications, and non-public information obtained based on data accumulated by individuals. This correction can be done manually or by using functions such as AI (artificial intelligence). According to the monitoring device 1 having the above-mentioned configuration, the intake amount of the ketogenic diet from the next time can be determined based on the determination result. In addition, it can be determined whether the animal is in a body condition or constitution that can effectively metabolize the ketogenic diet as a source of ketone bodies. Moreover, changes in the animal's physical condition or constitution can also be grasped by continuous recording. According to the monitoring device 1, regarding the ketogenic diet, patients and/or prospective patients with diseases that can be effectively treated by the ketogenic diet can be targeted for dietary management, such as adjusting the balance of sugars and lipids in the diet, etc. However, since the taste is not good, it may be difficult to ingest a large amount out of preference. However, the intake can be adjusted while monitoring by the monitoring device 1. Therefore, only a sufficient and necessary amount, that is, an appropriate amount can be ingested, thereby avoiding excessive consumption. Eat a ketogenic diet you don’t like. According to the monitoring device 1, the food intake of the ketogenic diet that can effectively maintain or improve body condition becomes clear. Therefore, it has the effect of enabling feeding animals (especially humans) to eat consciously or unconsciously. The monitoring device 1 may be a device that directly connects the determination part 32 that displays the determination of the measurement results and the determination display part 22 a that displays the determination to perform monitoring at one place, or may be a device that includes the above-mentioned measurement part 21 and the determination display through the communication circuit 4 The monitoring terminal device 2 of the part 22a is connected to the monitoring management device 3 having a data acquisition part 31 for processing data and a determination part 32 for determining the effectiveness of the ketogenic diet (Fig. 1). Examples of the communication circuit 4 include radio waves, various known wireless communication lines, wired communication lines, and the like. Monitoring can be in real time or with a certain time difference. In addition, monitoring can be performed at one place or at multiple places, such as the patient himself, doctors, nurses, examination technicians, nutritionists, management equipment, ketogenic diet producers, etc. In addition, it may also include a monitoring terminal device and a monitoring management device. The monitoring terminal device includes a measurement unit, a judgment display unit, and a judgment display unit that receives and displays judgments; the monitoring management device includes a data acquisition unit, a judgment unit, and a storage judgment unit. A judgment storage unit for making judgments, and a judgment judgment unit for making judgments based on the stored judgments (Fig. 2). The monitoring terminal device can be shaped like a watch or glasses, or can be in any form that is easy to wear on the body, such as an ornament or a belt. Furthermore, it is also possible to have a monitoring management server that manages a plurality of monitoring terminal devices in a coordinated manner. By monitoring the management server, for example, it can also be used to determine the usually optimal treatment amount based on the treatment results of multiple patients. As a monitoring terminal device or monitoring management device, all digital computers including personal computers and supercomputers can be used, as well as mobile phones, smart phones, tablets, alarm devices, etc. FIG. 3 is a functional block diagram showing the overall structure of the monitoring device of this embodiment. The monitoring terminal device 2 includes an acetone concentration measurement unit that measures the acetone concentration, and a display unit that displays data from a determination and other transmission unit. The display unit includes a determination display unit. Furthermore, it may also have a judgment display part which displays the data from the judgment etc. transmission part. Furthermore, one or a plurality of other measurement units useful for managing the effective state of the ketogenic diet may be included. The monitoring and management device 3 includes a data acquisition unit that acquires measurement data, a recording unit that records the measurement data, and a determination unit that determines the dietary amount of metabolized ketone bodies based on the data. In addition, it may also have a judgment storage part that stores judgments in advance, and a judgment part that checks or judges whether the food intake or fat amount of the diet needs to be adjusted based on the stored judgments, and whether the diet can be adapted to the ketogenic diet. The judgment from the judgment unit and the judgment from the judgment unit are sent to the judgment display unit or the judgment display unit via the judgment transmitting unit and displayed on the monitoring terminal device. The monitoring and management device may also include a data recording unit. FIG. 4 is a functional block diagram showing the structure of the monitoring device of this embodiment. The monitoring device 1 has monitoring terminal devices 2A to 2C, monitoring management devices 3A to 3C, and communication circuits 4A to 4C connecting them. It may have a plurality of monitoring terminal devices, or it may have one and/or a plurality of monitoring management devices that manage a plurality of monitoring terminal devices. Furthermore, it may also have a monitoring and management server for upper-level management of the monitoring and management device. The present invention includes methods of using the monitoring device of the present invention or methods of use, methods of evaluating ketogenic diet, methods of managing ketogenic diet intake, verification of animals that can be effectively treated with ketogenic diet, etc. using the monitoring device of the present invention. All forms and can be applied to all forms. The embodiments of the present invention have been described in detail above. However, the present invention is not limited to the above-described embodiments, and various design changes can be made without departing from the spirit of the present invention described in the claims.

1‧‧‧監測裝置2‧‧‧監測終端裝置2A‧‧‧監測終端裝置A2B‧‧‧監測終端裝置B2C‧‧‧監測終端裝置C3‧‧‧監測管理裝置3A‧‧‧監測管理裝置A3B‧‧‧監測管理裝置B3C‧‧‧監測管理裝置C4‧‧‧通信電路4A‧‧‧通信電路A4B‧‧‧通信電路B4C‧‧‧通信電路C5‧‧‧監測管理伺服器21‧‧‧測定部21a‧‧‧丙酮濃度測定部22‧‧‧顯示部22a‧‧‧判定顯示部31‧‧‧資料獲取部32‧‧‧判定部1‧‧‧Monitoring device 2‧‧‧Monitoring terminal device 2A‧‧‧Monitoring terminal device A2B‧‧‧Monitoring terminal device B2C‧‧‧Monitoring terminal device C3‧‧‧Monitoring and management device 3A‧‧‧Monitoring and management device A3B‧ ‧‧Monitoring and management device B3C‧‧‧Monitoring and management device C4‧‧‧Communication circuit 4A‧‧‧Communication circuit A4B‧‧‧Communication circuit B4C‧‧‧Communication circuit C5‧‧‧Monitoring and management server 21‧‧‧Measurement section 21a‧‧‧Acetone concentration measurement part 22‧‧‧Display part 22a‧‧‧Judgment display part 31‧‧‧Data acquisition part 32‧‧‧Judgment part

圖1係表示本實施形態之監測裝置之例之功能方塊圖。 圖2係表示本實施形態之監測裝置之例之功能方塊圖。 圖3係表示本實施形態之監測裝置之整體構成之功能方塊圖。 圖4係表示本實施形態之監測裝置之構成之功能方塊圖。FIG. 1 is a functional block diagram showing an example of the monitoring device of this embodiment. FIG. 2 is a functional block diagram showing an example of the monitoring device of this embodiment. FIG. 3 is a functional block diagram showing the overall structure of the monitoring device of this embodiment. FIG. 4 is a functional block diagram showing the structure of the monitoring device of this embodiment.

1:監測裝置 1:Monitoring device

2:監測終端裝置 2: Monitoring terminal device

3:監測管理裝置 3: Monitoring and management device

4:通信電路 4: Communication circuit

21:測定部 21: Measurement Department

21a:丙酮濃度測定部 21a: Acetone concentration measurement part

22:顯示部 22:Display part

22a‧‧‧判定顯示部 22a‧‧‧Judgment display part

31‧‧‧資料獲取部 31‧‧‧Data Acquisition Department

32‧‧‧判定部 32‧‧‧Judgment Department

Claims (6)

一種生酮飲食監測裝置,其特徵在於:其係對生酮飲食之有效性進行監測者,且具有:攝取資訊獲取部,其獲取攝取至動物體內之生酮飲食之攝取量之資訊;丙酮濃度測定部,其對自上述動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定;及判定部,其基於藉由上述攝取資訊獲取部所獲取之上述生酮飲食之攝取量之資訊、及藉由上述丙酮濃度測定部所測定之上述丙酮濃度之資訊,判定上述動物之上述生酮飲食之代謝狀態。 A ketogenic diet monitoring device, characterized in that it monitors the effectiveness of the ketogenic diet and has: an intake information acquisition unit that acquires information on the intake of the ketogenic diet into the animal's body; acetone concentration a measurement unit that measures the amount of acetone in the gas excreted from the body of the animal, that is, the acetone concentration; and a determination unit that is based on the information on the intake of the ketogenic diet acquired by the intake information acquisition unit, and The metabolic state of the ketogenic diet of the animal is determined based on the information on the acetone concentration measured by the acetone concentration measuring unit. 如請求項1之生酮飲食監測裝置,其中上述判定部係基於攝取上述生酮飲食前後之上述丙酮濃度之增減而進行上述判定。 The ketogenic diet monitoring device of claim 1, wherein the determination unit performs the determination based on the increase or decrease in the acetone concentration before and after ingesting the ketogenic diet. 如請求項2之生酮飲食監測裝置,其中於與攝取上述生酮飲食前相比,上述丙酮濃度表現出增加傾向之情形時,上述判定部判定上述動物係將上述生酮飲食作為酮體來源而代謝之狀態、或者上述動物係可將上述生酮飲食作為酮體來源而代謝之體況或體質。 The ketogenic diet monitoring device of Claim 2, wherein when the acetone concentration shows a tendency to increase compared with before ingesting the ketogenic diet, the determination unit determines that the animal uses the ketogenic diet as a source of ketone bodies. The metabolic state, or the body condition or constitution of the above-mentioned animal can metabolize the above-mentioned ketogenic diet as a source of ketone bodies. 一種生酮飲食攝取量之管理方法,其特徵在於:其係使用生酮飲食監測裝置者,該生酮飲食監測裝置具有:攝取資訊獲取部,其獲取攝取至動物體內之生酮飲食之攝取量之資 訊;丙酮濃度測定部,其對自上述動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定;及判定部,其基於藉由上述攝取資訊獲取部所獲取之上述生酮飲食之攝取量之資訊、及藉由上述丙酮濃度測定部所測定之上述丙酮濃度之資訊,判定上述動物之上述生酮飲食之代謝狀態;且該生酮飲食攝取量之管理方法包含下述步驟:測定步驟,其對上述丙酮濃度進行測定;算出步驟,其算出上述丙酮濃度之增加率;及調整步驟,其因應上述丙酮濃度之增加率而調整使上述動物攝取生酮飲食之攝取量。 A method for managing ketogenic diet intake, characterized in that it uses a ketogenic diet monitoring device, and the ketogenic diet monitoring device has an intake information acquisition unit that acquires the intake of ketogenic diet into an animal's body. capital information; an acetone concentration measurement unit that measures the amount of acetone in the gas excreted from the body of the animal, that is, the acetone concentration; and a determination unit that is based on the intake of the ketogenic diet acquired by the intake information acquisition unit The information of the above-mentioned acetone concentration measured by the above-mentioned acetone concentration measuring unit is used to determine the metabolic state of the above-mentioned ketogenic diet of the above-mentioned animal; and the management method of the ketogenic diet intake includes the following steps: a measuring step, It measures the above-mentioned acetone concentration; it calculates the increase rate of the above-mentioned acetone concentration; and it adjusts the intake amount of the ketogenic diet for the above-mentioned animal according to the above-mentioned increase rate of the acetone concentration. 如請求項4之生酮飲食攝取量之管理方法,上述調整步驟中,於上述丙酮濃度之增加率較預先設定之基準值為大之情形時,使上述生酮飲食之攝取量增加,於上述增加率為上述基準值以下之情形時,使上述生酮飲食之攝取量減少。 If the method for managing the intake of the ketogenic diet is requested in item 4, in the above adjustment step, when the increase rate of the acetone concentration is greater than the preset reference value, the intake of the above-mentioned ketogenic diet is increased. When the increase rate is below the above-mentioned reference value, the intake of the above-mentioned ketogenic diet will be reduced. 如請求項5之生酮飲食攝取量之管理方法,上述測定步驟中,係於使上述動物攝取上述生酮飲食之前後,各自對上述丙酮濃度進行測定,且上述算出步驟中,係基於攝取上述生酮飲食前後之上述丙酮濃度之差,算出上述丙酮濃度之增加率。 In the method for managing the intake of a ketogenic diet according to claim 5, in the measuring step, the acetone concentration is measured before and after the animal ingests the ketogenic diet, and in the calculating step, the acetone concentration is measured based on the intake of the ketogenic diet. The difference in the acetone concentration before and after the ketogenic diet was used to calculate the increase rate of the acetone concentration.
TW107111853A 2017-04-06 2018-04-03 Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake TWI816666B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017076201 2017-04-06
JP2017-076201 2017-04-06
JP2017162775A JP6968624B2 (en) 2017-04-06 2017-08-25 How to manage ketogenic diet intake
JP2017-162775 2017-08-25

Publications (2)

Publication Number Publication Date
TW201842316A TW201842316A (en) 2018-12-01
TWI816666B true TWI816666B (en) 2023-10-01

Family

ID=64275121

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107111853A TWI816666B (en) 2017-04-06 2018-04-03 Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake

Country Status (3)

Country Link
JP (1) JP6968624B2 (en)
CN (1) CN110506211A (en)
TW (1) TWI816666B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7361517B2 (en) * 2018-07-17 2023-10-16 大阪瓦斯株式会社 Index value determination system, mitochondrial activity evaluation system, index value determination method, and mitochondrial activity evaluation method
JPWO2020066839A1 (en) 2018-09-26 2021-10-07 パナソニックIpマネジメント株式会社 Warm color composite phosphor, wavelength converter and light emitting device
JPWO2020255743A1 (en) * 2019-06-18 2020-12-24
WO2021140640A1 (en) * 2020-01-10 2021-07-15 大阪瓦斯株式会社 Index value determination system, mitochondrial activiy evaluation system, index value determination method, and mitochondrial activity evaluation method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105241828A (en) * 2015-08-19 2016-01-13 苏州华和呼吸气体分析研究所有限公司 CRDS acetone breath analyzer for noninvasively measuring blood ketone body level
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
CN106338597A (en) * 2016-10-18 2017-01-18 哈尔滨工业大学深圳研究生院 Respiratory gas measuring method and system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3822076B2 (en) * 2001-09-11 2006-09-13 株式会社タニタ Blood ketone body concentration measuring device
CN103503016B (en) * 2011-09-14 2017-02-15 株式会社Ntt都科摩 Diet support system and diet support method
CN105050594B (en) * 2013-03-19 2019-11-12 南佛罗里达大学 For generating the composition and method that increase with lasting ketosis
CN103268414A (en) * 2013-05-20 2013-08-28 吉林市同益科技开发有限公司 Phenylketonuria managing method and system
JP2015141458A (en) * 2014-01-27 2015-08-03 株式会社タニタ diet support device, method, and program
CN107111855A (en) * 2015-01-07 2017-08-29 株式会社Ntt都科摩 Information processor, calorie management system, calorie revenue and expenditure method of estimation and program
CN107921133A (en) * 2015-09-04 2018-04-17 国立大学法人大阪大学 The dietetic treatment exploitation of cancer
US10736548B2 (en) * 2016-05-18 2020-08-11 Invoy Holdings, Inc. Ketone measurement system for monitoring medical conditions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
CN105241828A (en) * 2015-08-19 2016-01-13 苏州华和呼吸气体分析研究所有限公司 CRDS acetone breath analyzer for noninvasively measuring blood ketone body level
CN106338597A (en) * 2016-10-18 2017-01-18 哈尔滨工业大学深圳研究生院 Respiratory gas measuring method and system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
期刊 , G NERI, et al., "Design and development of a breath acetone MOS sensor for ketogenic diets control", IEEE Sensors Journal, 10(1), IEEE, 2010: 131~136. *

Also Published As

Publication number Publication date
CN110506211A (en) 2019-11-26
TW201842316A (en) 2018-12-01
JP6968624B2 (en) 2021-11-17
JP2018179960A (en) 2018-11-15

Similar Documents

Publication Publication Date Title
TWI816666B (en) Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake
Uthaya et al. Altered adiposity after extremely preterm birth
Gupta et al. Indirect calorimetry: from bench to bedside
Lévy et al. Obstructive sleep apnoea syndrome
Peters et al. Major surgery within the first 3 months of life and subsequent biobehavioral pain responses to immunization at later age: a case comparison study
Nena et al. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea
Klebermass-Schrehof et al. Can neurophysiological assessment improve timing of intervention in posthaemorrhagic ventricular dilatation?
Workman et al. Post-metabolic response to passive normobaric hypoxic exposure in sedendary overweight males: a pilot study
Dickey et al. Hypoxic ischemic encephalopathy—what can we learn from humans?
Archbold et al. Neural activation patterns during working memory tasks and OSA disease severity: preliminary findings
Braun et al. Evaluation of eating and rumination behaviour using a noseband pressure sensor in cows during the peripartum period
Daly-Wolfe et al. Mid-arm circumference is a reliable method to estimate adiposity in preterm and term infants
Kanoore Edul et al. The effects of arterial hypertension and age on the sublingual microcirculation of healthy volunteers and outpatients with cardiovascular risk factors
Durand et al. Sleep-disordered breathing in newborn mice heterozygous for the transcription factor Phox2b
de Melo et al. Relationship of evening meal with sleep quality in obese individuals with obstructive sleep apnea
Vesoulis et al. Early hyperoxia burden detected by cerebral near-infrared spectroscopy is superior to pulse oximetry for prediction of severe retinopathy of prematurity
Huang et al. Comparison of cardiovascular co-morbidities and CPAP use in patients with positional and non-positional mild obstructive sleep apnea
Idris et al. Relationship between chewing features and body mass index in young adolescents
Acosta et al. Sleep duration and quality are not associated with brown adipose tissue volume or activity—as determined by 18F-FDG uptake, in young, sedentary adults
Choudhary et al. The link between brain acidosis, breathing and seizures: a novel mechanism of action for the ketogenic diet in a model of infantile spasms
Çekici et al. Determining energy requirement and evaluating energy expenditure in neurological diseases
Basterfield et al. Wheel running in female C57BL/6J mice: impact of oestrus and dietary fat and effects on sleep and body mass
Burchert et al. Aerobic exercise training response in preterm-born young adults with elevated blood pressure and stage 1 hypertension: a randomized clinical trial
Castro et al. Oral motor function in obesity
Wowdzia et al. Glycemic response to acute high‐intensity interval versus moderate‐intensity continuous exercise during pregnancy